Dario Move to be deployed in Greece and Cyprus to help improve the musculoskeletal health of the general populations New York, Dec. 22, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the...
|
DarioHealth Corp. (NASDAQ: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced the publication of a new study in the peer-reviewed journal Frontiers in...
|
The new accounts originated through an existing relationship with a benefits brokerage and provide further validation of Dario's partnership Strategy. NEW YORK, Dec. 1, 2022 /PRNewswire/ --...
|
DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today that management will participate at the following conferences: 13th...
|
Third quarter 2022 revenues of $6.6 million increased 17.3% from $5.6 million in the third quarter of 2021 driven by growth in Business-to-Business (B2B) revenues. Nine-month year to date revenue...
|
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the third quarter ended September 30, 2022,...
|
New 'jumbo' employer account represents increasing penetration of the Dario platform NEW YORK, Oct. 20, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader...
|
Oct 13, 2022 Dario to support City employees with integrated solutions addressing diabetes, hypertension, weight management, musculoskeletal and behavioral health in company's first government contract win NEW...
|
New research sheds light on the importance of training to drive healthier posture NEW YORK, Sept. 22, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital...
|
New accounts demonstrate continued demand for integrated and holistic digital chronic condition management solutions NEW YORK, Sept. 20, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the...
|
Q2 revenue of 6.2 million, a 17.5% increase from the $5.3 million of the second quarter of 2021. Six-month year-to-date revenue totaled $14.2 million, a 60.8% increase over the first six months of...
|
The research examines Dario's ability to improve the health of members in rural areas compared to their urban counterparts and found the solution to be equally effective NEW YORK, Aug. 12, 2022...
|
Dario's digital behavioral health solution will help to improve access and navigation across mental health resources NEW YORK, Aug. 11, 2022 /PRNewswire/ -- DarioHealth Corp. ("Dario",...
|
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the second quarter ended June 30, 2022, on...
|
The studies underscore the value of Dario's integrated behavioral health solution to help more people connect to effective care that is right for their needs NEW YORK, Aug. 4, 2022 /PRNewswire/ --...
|
Demand for Dario's single approach to chronic condition management continues to show strong demand NEW YORK, July 21, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global...
|
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced a new contract to deliver its digital behavioral health solution for a leading provider...
|
Investment from Elite Healthcare Fund Provides Validation, Access to Capital and Significant Runway to Execute on Strategic Operating Plan NEW YORK, June 9, 2022 /PRNewswire/ -- DarioHealth Corp....
|
The studies demonstrated significant improvement in glucose control and reductions in blood pressure for users managing diabetes and hypertension and improvement in clinical measures for users...
|
Two new B2B contracts reinforce Dario's position as an emerging leader in multi-chronic digital health NEW YORK, May 19, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the...
|
Total Q1 revenue of $8.06 million increased 124% over the comparable prior year period and 34% sequentially over Q4 2021 Accelerated Business-to-Business (B2B) transformation with 14 new B2B...
|
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the first quarter ended March 31, 2022 on...
|
New research offers fresh evidence that a single digital therapeutics platform can improve outcomes for commonly co-occurring conditions NEW YORK, April 27, 2022 /PRNewswire/ -- DarioHealth Corp....
|
New health plan partnership improves access to digital health for historically underserved populations NEW YORK, April 14, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the...
|
Dario continues rapid expansion of employer business across multi-condition suite of solutions DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today two new employer agreements: first, with a U.S. based social platform employer and...
|
| |